These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21747237)

  • 1. Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient.
    van den Berk GE; Arends JE
    AIDS; 2011 Jul; 25(12):1553-4. PubMed ID: 21747237
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increasing chances. Effective HCV therapy lowers mortality of HIV infection].
    MMW Fortschr Med; 2003 Jun; 145(26):53. PubMed ID: 12916340
    [No Abstract]   [Full Text] [Related]  

  • 3. Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV.
    Rachline A; Palmer P; Simon F; Molina JM
    J Med Virol; 2010 Jul; 82(7):1150-1. PubMed ID: 20513077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse.
    Labarga P; Barreiro P; Mira JA; Vispo E; Rallón N; Neukam K; Camacho A; Caruz A; Rodriguez-Novoa S; Pinilla J; Rivero A; Benito JM; Pineda JA; Soriano V
    AIDS; 2011 May; 25(8):1131-3. PubMed ID: 21537116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive use of ribavirin and prolonged course of peginterferon to improve the rate of viral response in liver transplant patients with recurrent hepatitis C viral infection.
    Singhal A; Jain AB; Burke M; Black M
    Exp Clin Transplant; 2010 Sep; 8(3):214-9. PubMed ID: 20716039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
    Andriulli A; Mangia A
    N Engl J Med; 2007 Oct; 357(16):1660; author reply 1661-2. PubMed ID: 17942881
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
    Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
    J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV.
    Liu CH; Chen DS; Kao JH
    N Engl J Med; 2007 Oct; 357(16):1661; author reply 1661-2. PubMed ID: 17948345
    [No Abstract]   [Full Text] [Related]  

  • 9. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the treatment of hepatitis B and C co-infection in HIV patients].
    Mauss S
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():27-9. PubMed ID: 15373041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort.
    Wojcik K; Vogel M; Voigt E; Speidel N; Kalff JC; Goldmann G; Oldenburg J; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2007 Jun; 21(10):1363-5. PubMed ID: 17545715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
    Hornberger J; Torriani FJ; Dieterich DT; Bräu N; Sulkowski MS; Torres MR; Green J; Patel K
    J Clin Virol; 2006 Aug; 36(4):283-91. PubMed ID: 16765638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PegIFN/ribavirin during acute HCV coinfection.
    Bernard EJ
    IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
    [No Abstract]   [Full Text] [Related]  

  • 14. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients.
    Rivero-Juárez A; Mira JA; Pérez-Camacho I; Macías J; Camacho A; Neukam K; Torre-Cisneros J; Merchante N; Pineda JA; Rivero A;
    J Antimicrob Chemother; 2011 Jun; 66(6):1351-3. PubMed ID: 21415037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

  • 16. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice. Conclusions].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S118-9. PubMed ID: 19375040
    [No Abstract]   [Full Text] [Related]  

  • 17. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 18. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.
    Gozlan J; Lacombe K; Gault E; Raguin G; Girard PM
    J Hepatol; 2009 Feb; 50(2):432-4. PubMed ID: 19070927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.